Aim: To investigate the relationship between somatic health problems and comorbid condition of anxiety and depression.
Methods: The cross-sectional study in a population of 2,000 students of the Belgrade University (four schools: Medicine, Geography, Economics, Electrical Engineering) during the period April - June 2010 was conducted. The students were randomly selected. The main instrument for data collection was a standardized epidemiological questionnaire, designed at the Institute of Epidemiology, School of Medicine in Belgrade.
Results: According to the Hamilton Depression Scale (HAMD), correlation was found between the following somatic diseases and depression: diabetes (p=0.003), hypertension (p=0.007), heart disease (p=0.001), chronic bronchitis (p=0.033), neurological diseases (p=0.013), and gastric or duodenal ulcer (p=0.003). According to the Hamilton Anxiety Scale (HAMA) a correlation was found between the following somatic diseases and anxiety: diabetes (p=0.020), hypertension (p less than 0.001), heart disease (p=0.000), chronic bronchitis (p=0.037), bronchial asthma (p=0.049), gastric or duodenal ulcer (p=0.003).
Conclusion: Depression and anxiety are common in persons with somatic diseases and have a significant association with physical health. This has considerable implications for somatic diseases management and clinical guidelines.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Familial Platelet Disorder with associated Myeloid Malignancy (FPDMM, FPD/AML, -FPD), caused by monoallelic deleterious germline variants, is characterized by bleeding diathesis and predisposition for hematologic malignancies, particularly myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). Clinical data on FPDMM-associated AML (FPDMM-AML) are limited, complicating evidence-based clinical decision-making. Here, we present retrospective genetic and clinical data of the largest cohort of FPDMM patients reported to date.
View Article and Find Full Text PDFPredicting work ability impairment in post COVID-19 patients: a machine learning model based on clinical parameters.
Infection
January 2025
Department of Medicine II, LMU University Hospital, LMU Munich, Munich, Germany.
The Post COVID-19 condition (PCC) is a complex disease affecting health and everyday functioning. This is well reflected by a patient's inability to work (ITW). In this study, we aimed to investigate factors associated with ITW (1) and to design a machine learning-based model for predicting ITW (2) twelve months after baseline.
View Article and Find Full Text PDFRat Models of Breast Cancer.
Adv Exp Med Biol
January 2025
Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA.
As the first mammal to be domesticated for research purposes, rats served as the primary animal model for various branches of biomedical research, including breast cancer studies, up until the late 1990s and early 2000s. During this time, genetic engineering of mice, but not rats, became routine, and mice gradually supplanted rats as the preferred rodent model. But recent advances in creating genetically engineered rat models, especially with the assistance of CRISPR/Cas9 technology, have rekindled the significance of rats as a critical model in exploring various facets of breast cancer research.
View Article and Find Full Text PDFExploiting somatic oncogenic driver alterations in a patient with Li-Fraumeni syndrome- paving the path towards precision medicine: a case report.
J Cancer Res Clin Oncol
January 2025
Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany.
Background: Li-Fraumeni syndrome (LFS) is an autosomal dominant tumor predisposition syndrome characterized by a high familial incidence of various malignancies. It results from pathogenic/likely pathogenic heterozygous constitutional variants of the TP53 gene. Due to impaired DNA damage repair, conventional cytotoxic therapies or radiotherapy should be avoided whenever feasible to mitigate the high incidence of treatment-related secondary malignancies in these patients.
View Article and Find Full Text PDFVEXAS syndrome: is it more a matter of inflammation or hematopoietic clonality? A case series approach to diagnosis, therapeutic strategies and transplant management.
Ann Hematol
January 2025
Hematology, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, 09121, Italy.
VEXAS syndrome is a complex hemato-inflammatory disorder, driven by somatic mutations in the UBA1 gene within hematopoietic precursor cells. It is characterized by systemic inflammation, rheumatological manifestations, and frequent association with myelodysplastic syndrome (MDS). We present a series of four VEXAS cases, all of which include concomitant MDS, each displaying distinct genetic signatures and clinical features at diagnosis, with a focus on their diagnostic and therapeutic implications.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!